Episode Details
Back to Episodes
May and Baker H1 2026
Published 2 months ago
Description
May and Baker is the third largest pharmaceutical company by revenue on the NGX. Here is a look at its H1 2026 earnings and where i feel the stock should be trading at in the mid to long term.